Galectin Therapeutics Profit Margin

Galectin Therapeutics profit margin — quarterly history, peer benchmarks, and growth trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

N/A

As of Mar 2026

Annual Profit Margin (TTM)

N/A

Trailing 12 months ending Mar 2026

Average Profit Margin (Comparison Companies)

Profit Margin History

Profit Margin Comparison

Annual Profit Margin Growth Rate (%)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin

Galectin Therapeutics (GALT) FAQ

Stockcircle tracks profit margin for Galectin Therapeutics (GALT), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Profit Margin page is built for Galectin Therapeutics's historical profit margin trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use profit margin as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main GALT overview so you can move from this figure to the surrounding analysis quickly.